Journal Information

Statistics

Follow this link to access the full text of the article

Brief Comunication
52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience
Eficacia a medio plazo (52 semanas) de tildrakizumab en el tratamiento de la psoriasis moderada a severa: un estudio multicéntrico de práctica clínica
F.J. Melgosa Ramosa,
, A. Mateu Puchadesa, J. Matáix-Díazb, L. Schneller-Pavelescuc, I. Belinchón-Romerod, S. Santos Alarcóne
a Department of Dermatology, University Hospital Doctor Peset of Valencia, Valencia, Spain
b Department of Dermatology, Hospital Marina Alta, Vila-Joyosa, Alicante, Spain
c Department of Dermatology, Hospital de la Vega Baja, Orihuela, Alicante, Spain
d Department of Dermatology, General University Hospital of Alicante, Alicante, Spain
e Department of Dermatology, University Hospital Virgen de los Lirios, Alcoy, Alicante, Spain
Read
4485
Times
was read the article
995
Total PDF
3490
Total HTML
Share statistics
Article information
ISSN: 00017310
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 8 16 3 19
2025 7 202 44 246
2025 6 345 40 385
2025 5 342 57 399
2025 4 281 38 319
2025 3 240 46 286
2025 2 287 65 352
2025 1 184 45 229
2024 12 157 54 211
2024 11 159 88 247
2024 10 145 69 214
2024 9 137 54 191
2024 8 222 105 327
2024 7 207 60 267
2024 6 174 64 238
2024 5 182 56 238
2024 4 210 107 317
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?